Hospital Pharmacy Europe - Industry News,

Click here

Thursday 23 May 2013 Register Login

You are here:

Suppliers Guide

New neurology product

Hospital Pharmacy Europe is assisting with a survey on messaging for a new neurology product. Click here

LATEST ISSUE

Contamination control and preparation of anticancer drugs, medicines reconciliation, Ruconest drug evaluation, ivacaftor for cystic fibrosis , oxycodone-naloxone prolonged-release tablets, IV chemotherapy, capsaicin in the treatment of severe neuropathic pain, alitretinoin in severe chronic hand eczema, Zyclara for actinic keratoses

Pharmacy Zone: Industry News

Magazine	Sponsored content
News	Video

Page:

6

Tue 2 Oct
2012

Clinical proof-of-concept
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) has announced the initial clinical results on its investigational, tyrosine-kinase...

Mon 1 Oct
2012

Progression-free survival benefit with afatinib*
Data from LUX-Lung 3, the largest and most robust registration trial to date** in patients with EGFR (ErbB1) mutation positive...

Mon 1 Oct
2012

Phase I/II ARADES trial of a new generation anti-androgen
Dr Christophe Massard, MD, investigator in ODM-201 ARADES trial presented initial results from the Phase I component of the...

Mon 1 Oct
2012

Subcutaneous VELCADE® approved in the EU
Janssen-Cilag International NV (Janssen) has announced that the European Commission has granted marketing authorisation for the...

Mon 1 Oct
2012

New four- and five-year survival data for YERVOY®
Bristol-Myers Squibb Company today announced four- and five-year survival rates based on long-term follow up from Phase 3 and...

Mon 1 Oct
2012

STELARA® and moderate to severe plaque psoriasis
A series of data presentations released today at the 21st European Academy of Dermatology and Venereology (EADV) congress, in...

Fri 28 Sep
2012

FDA approves regorafenib
On September 27, 2012, the US Food and Drug Administration approved regorafenib (Stivarga tablets, Bayer HealthCare...

Thu 27 Sep
2012

Change in the Board of Managing Directors at Boehringer Ingelheim
Mr Engelbert Tjeenk Willink, Member of the Board of Managing Directors at Boehringer Ingelheim GmbH and responsible for Marketing...

Thu 27 Sep
2012

Novartis data in patients with plaque psoriasis
Novartis announced today new Phase II data showing AIN457 (secukinumab) may significantly improve moderate-to-severe plaque...

Thu 27 Sep
2012

Biogen Idec and Sobi announce positive top-line results
Biogen Idec (NASDAQ: BIIB) and Swedish Orphan Biovitrum (Sobi) (STO: SOBI) have announced positive results from B-LONG, a...

Thu 9 Aug
2012

Lundbeck financial expectation on track
H. Lundbeck A/S (Lundbeck) reports first half revenue of DKK 6,829 million, excluding Lexapro® in the US, an increase of 1%...

Tue 31 Jul
2012

NicOx releases first half 2012 results
Financial results for first six months of 2012, ending on June 30, have been released with an update on activities

Tue 31 Jul
2012

Otsuka receives FDA response for aripiprazole
Otsuka and Lundbeck received a complete response letter to the application for new formulation of aripiprazole

Tue 31 Jul
2012

BioIndustry Association launches partnering conference
BIA UK Bioscience Forum will hold a conference discussing key bioscience issues on 4 October

Mon 16 Jul
2012

Orion interim report 'will be published at end July'
The January to July interim report will be published on Tuesday 31 July at about 12:00 Finnish time

Fri 13 Jul
2012

Apremilast reaches significance in psoriatic arthritis
Clinically meaningful, significant improvements were noted in signs, symptoms and physical function

Fri 13 Jul
2012

NicOx to hold extraordinary shareholder meeting
The meeting on second call will be held on Friday 27 July at Mercure Hotel in Soophia Antipolis, France

Thu 12 Jul
2012

Index Ventures discusses €150mn life sciences fund
Partner Kevin Johnson spoke about the fund at Bioindustry Association's UK CEO and Investor Forum

Mon 9 Jul
2012

Harvard, Boehringer Ingelheim collaborate in research
Boehringer Ingelheim announces its translation research collaboration with Presidents and Fellows of Harvard

Mon 9 Jul
2012

B Braun announces sixth workshop on injection safety
The workshop will look at strategies to improve patient safety with injectable drugs

Page:

6

Web design, hosting and programming by ModeZero